General Information of the Compound
Compound ID
CP0453360
Compound Name
(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S,3R)-2-[[(2S,3S)-2-[[(3R,6S,9S,14S,17R,20S,23R,26S,29R,32S,35R,38S)-3-(4-aminobutyl)-9-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-17-(2-amino-2-oxoethyl)-20-[(2S)-butan-2-yl]-29-(3-carbamimidamidopropyl)-6-(hydroxymethyl)-26-(1H-imidazol-5-ylmethyl)-23-[(4-methoxyphenyl)methyl]-14,35-dimethyl-32-(2-methylpropyl)-2,5,8,12,16,19,22,25,28,31,34,37-dodecaoxo-1,4,7,13,15,18,21,24,27,30,33,36-dodecazabicyclo[36.3.0]hentetracontane-14-carbonyl]amino]-3-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid
    Show/Hide
Structure
Formula
C108H168N34O28
Molecular Weight
2390.742
Canonical SMILES
CC[C@H](C)[C@H](NC(=O)[C@@]1(C)NC(=O)CC[C@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)C(=O)N[C@@H](CO)C(=O)N[C@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@H](Cc2ccc(OC)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC(N)=O)C(=O)N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O
    Show/Hide
InChI
InChI=1S/C108H168N34O28/c1-11-55(5)83-99(163)134-76(50-81(112)148)97(161)141-108(9,104(169)139-84(56(6)12-2)100(164)138-85(58(8)144)101(165)129-69(22-17-43-122-107(117)118)88(152)128-70(36-38-80(111)147)91(155)126-68(21-16-42-121-106(115)116)90(154)135-77(103(167)168)48-60-26-32-64(146)33-27-60)140-82(149)39-37-71(125-87(151)66(110)46-59-24-30-63(145)31-25-59)92(156)136-78(52-143)96(160)130-72(19-13-14-40-109)102(166)142-44-18-23-79(142)98(162)124-57(7)86(150)131-73(45-54(3)4)93(157)127-67(20-15-41-120-105(113)114)89(153)133-75(49-62-51-119-53-123-62)94(158)132-74(95(159)137-83)47-61-28-34-65(170-10)35-29-61/h24-35,51,53-58,66-79,83-85,143-146H,11-23,36-50,52,109-110H2,1-10H3,(H2,111,147)(H2,112,148)(H,119,123)(H,124,162)(H,125,151)(H,126,155)(H,127,157)(H,128,152)(H,129,165)(H,130,160)(H,131,150)(H,132,158)(H,133,153)(H,134,163)(H,135,154)(H,136,156)(H,137,159)(H,138,164)(H,139,169)(H,140,149)(H,141,161)(H,167,168)(H4,113,114,120)(H4,115,116,121)(H4,117,118,122)/t55-,56-,57+,58+,66-,67+,68-,69-,70-,71-,72+,73-,74+,75-,76+,77-,78-,79-,83-,84-,85-,108-/m0/s1
    Show/Hide
InChIKey
VBTUXOMDWJFMCN-HCGXBGOBSA-N
Physicochemical Property
logP
-9.40679
Rotatable Bonds
53
Heavy Atom Count
170
Polar Areas
1024.16
Hydrogen Bond Donor Count
37
Hydrogen Bond Acceptor Count
33
Complexity
170

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 91928643
ChEMBL ID
CHEMBL437482
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02259, Neuropeptide Y receptor type 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000074 SK-N-MC Homo sapiens (Human)  1
1
Kd > 1000 nM
   TI
   LI
   LO
   TS